Concerning ENO2, literature reports indicated upregulation in cancer [47,48] rather than downregulation, as it occurred in our mutant transfected cells, but additional studies are needed to find any specific correlation of this subunit of the enolase in CRC and KRAS/BRAF mutations. The gene discussed is KRAS; the disease is cancer.